However, ACE-I utilization declined in 2012 and was being replaced by diuretics, which may have important clinical implications in the prevention of complications in hypertension patients with co-morbid conditions such as diabetes, such as renal impairment, and warrants further investigation. The gene discussed is ACE; the disease is hypertensive disorder.